DGX
Stock Details
DGX is Quest Diagnostics Incorporated's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 141.15$. Average daily volumn in 3 months 1.19M. Market cap 16.00B
Stock symbol : DGX. Exchange : NYSE. Currency : USD Lastest price : 141.48$. Total volume : 878.52k. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Quest Diagnostics Incorporated (DGX)
Last Price
141.48$Change
2.19Volume
878.52k
| Previous Close | 139.29 |
| Open | 139.86 |
| Day Range | 139.75-141.76 |
| Bid | 141.37 x 900 |
| Ask | 144.55 x 900 |
| Volume | 878.52k |
| Average Volume | 1.19M |
| Market Cap | 16B |
| Beta | 0.94 |
| 52 Week Range | 120.40-158.34 |
| Trailing P/E | 17.75 |
| Foward P/E | 15.36 |
| Dividend (Yield %) | 2.04% |
| Ex-Dividend Date | 2023-04-06 |
Financial Details
Organization
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brand... s to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Market Cap:
16.00BRevenue:
9.88BTotal Assets:
12.84BTotal Cash:
315M
News about "Quest Diagnostics Incorporated"
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Source from : YAHOO!Finance - 4 days ago
Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.See details»
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day
Source from : MarketWatch - 3 days ago
Shares of Quest Diagnostics Inc. slumped 0.46% to $138.79 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with ...See details»
Quest Diagnostics Inc
Source from : Newsweek - 21 days ago
Quest Diagnostics Incorporated is a Fortune 500 American company providing clinical laboratory services with headquarters in Secaucus, New Jersey. Founded in 1967 as Metropolitan Pathology ...See details»
Quest Diagnostics Incorporated (DGX) Shares Up Despite Recent Market Volatility
Source from : newsheater - 10 days ago
Quest Diagnostics Incorporated (NYSE: DGX)’s stock price has increased by 2.26 compared to its previous closing price of 132.91. Nevertheless, the company has seen a 1.50% surge in its stock price ...See details»
Quest Diagnostics Incorporated
Source from : Fortune - 3 years ago
© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»
Quest Diagnostics Remains A Solid Long-Term Company
Source from : Seeking Alpha - 12 days ago
While Quest Diagnostics Incorporated's (NYSE:DGX) profitability margins have been affected in the short term, the company remains financially stable with solid cash flow from operations.See details»
Quest Diagnostics (DGX) Introduces New Post-COVID-19 Panels
Source from : YAHOO!Finance - 5 days ago
Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers ...See details»
Problem Solved: Overcharged by Quest Diagnostics – can she get her $353 back?
Source from : Green Valley News - 2 days ago
Q: I received two bills from Quest Diagnostics for tests that my insurance denied. I paid the bills myself, not knowing that my doctors had already recoded them and resubmitted ...See details»
Quest Diagnostics (DGX) Acquires Northern Light Laboratory
Source from : Nasdaq - 11 days ago
Quest Diagnostics, Inc. DGX announced the closure of its previously announced acquisition of select assets of Northern Light Laboratory -- a large integrated healthcare system in Maine.See details»
Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day
Source from : MarketWatch - 16 days ago
Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day Mar 16, 2023 (PRNewswire via ...See details»
Quest Diagnostics Incorporated Common Stock (DGX)
Source from : Nasdaq - 10 years ago
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...See details»
Analyst Expectations for Quest Diagnostics's Future
Source from : Benzinga.com on MSN - 15 days ago
Stay up to date on Quest Diagnostics analyst ratings. What Are Analyst Ratings? Ratings come from analysts, or specialists within banking and financial systems that report for spe ...See details»
Overcharged For Medical Tests, Can A Refund Be Received
Source from : InkFreeNews - 6 days ago
Can she get it back or is it lost forever? I received two bills from Quest Diagnostics for tests that my insurance denied. I paid the bills myself, not knowing that my doctors had already recoded them ...See details»
Summa Health to sell lab business to Quest Diagnostics
Source from : Cleveland.com - 25 days ago
TWINSBURG, Ohio - Diagnostic testing services company Quest Diagnostics Inc. has agreed to acquire select assets of Summa Health’s outreach laboratory services business, referred to as LabCare Plus.See details»